Global
-
-
-
-
-
-
-
-
Nicotinamide adenine dinucleotide (NAD+)
Nicotinamide adenine dinucleotide (NAD+) is a core coenzyme present in all living cells of the human body. It dynamically transforms between oxidized and reduced states, playing a crucial role in key life processes.
-
Semaglutide
Semaglutide has been shown to significantly reduce weight, especially in patients with diabetes.
-
SLU-PP-332 peptides
A new drug can mimic the effects of exercise to promote muscle growth, improve physical performance, and potentially treat conditions caused by lack of exercise, such as obesity and muscle atrophy.
-
New Weight Loss Drug Retatrutide: Significant Weight Loss
Recent news reports the latest research progress on the next-generation weight loss drug Retatrutide.
-
Retatrutide – ushering in the era of “triple receptor agonists” for weight loss?
Studies showed that, with weekly administration, at week 24, overweight/obese non-diabetic subjects in the retatrutide 12mg group experienced a mean weight loss of 18.7 kg (17.5%); in the secondary endpoint, the retatrutide 12mg group achieved a mean weight loss of 26.2 kg (24.2%) at the end of week 48 treatment.
